Abstracts are hereby solicited for any of the following special sessions, any general related topics or the evening poster session:

Special Sessions
17–19 May 2011

Patent and Regulatory Issues
Chair: Dr. Jeremy Cockcroft, Department of Chemistry, Faculty of Mathematical and Physical Sciences,University
College London, London, UK

Formulation & Product Development
Chair: Dr. Shawn Yin, Principal Scientist, Bristol-Myers Squibb Company, New Brunswick, NJ, U.S.A.

Polymorph & Salt Screening
Chair: Dr. Gregory A. Stephenson, Research Advisor, Eli Lilly and Company, Indianapolis, IN, U.S.A.

Complementary Techniques
Chair: Dr. Julien Giovannini, AstraZeneca, Nottingham, U.K.

Amorphous, Activated and Nanomaterials
Chair: Dr. Simon Billinge, Professor of Materials Science and of Applied Physics & Applied Mathematics, Columbia
University, New York, NY, U.S.A.

New Frontiers in XRD in Pharmaceutical R&D
Chair: Dr. Cyrus Crowder, Principal Scientist, International Centre for Diffraction Data, Newtown Square, PA, U.S.A.

XRPD Structural Techniques (Acquisition and Use of XRPD Data, Indexing, Structure Determination, Rietveld Refinement)
Chair: Dr. Hideo Toraya, Rigaku Corporation, Tokyo, Japan

Crystal Structure Prediction
Chair: Dr. Jamshed Anwar, Professor of Computational Pharmaceutical Science & Director of Research, University of
Bradford, West Yorkshire, UK

Deadline for Receipt of Abstracts - 1 March 2011

 

Guidelines for Preparing Abstracts

Abstracts will be printed in the Symposium Book of Abstracts and will also be posted on the ICDD web site. If you do not want your abstract posted on the web site, please note your request when submitting your abstract. Abstracts must not exceed one page in length and must include the title, author(s), affiliation(s), and the text. To provide uniformity, it is recommended that abstracts be prepared according to the following guidelines.

Abstract Format

Paper Size: 8.5 x 11 inches; A4 paper must be formatted for 8.5 x 11 inches

Abstract Size: Entire abstract, including title, author(s), affiliation(s), and text, must fit into a maximum area of 15 cm (5.9") wide by 20 cm (7.9") high. Please allow a top margin of 3.8 cm (1.5") and 2.54 cm (1") margins on all other sides

Font: Times or Times New Roman, 12 point

Title: bold, centered, all UPPERCASE (except where lowercase letters are needed for clarity)

Spacing: Leave one blank line between the title and the author(s)

Author(s) & affiliation(s): mixed upper and lowercase, centered; if there is more than one author, underline the presenting author’s
name

Text:

  • Leave two blank lines before beginning text
  • Text should appear flush left; do not indent
  • Use line spacing sufficiently large enough to allow the abstract to be read easily, including subscripts, superscripts and Greek letters
  • A blank line is recommended (space permitting) between new paragraphs

Submission

Abstracts may be submitted on the web or by e-mail.
Web submission is the preferred method.

1. Web:

Submission is closed

2. E-mail:

Send as an attached Adobe® PDF (preferred format) or Micro soft® Word (Word 97 through Word 2007).

Pictures and graphs are acceptable but file size should not exceed 1 MB. Send attached files to: ppxrd@icdd.com.

PLEASE NOTE: If submitting a Microsoft® Word file, please minimize the use of special characters, tables,mathematical formulae and figures. If special symbols or Greek letters are used, please limit the fonts to those that are available with the standard distribution of Microsoft® Word. Nonstandard fonts may lead to errors in transmission. All graphics must be embedded in the Word document.

Authors who submit their abstracts by e-mail must submit a separate page with the following information:
■ Permission to post on the ICDD web site
■ Speaker’s name, mailing address, phone number, fax number, and e-mail address
■ If the speaker is not the person to whom correspondence should be sent, please include contact person’s name, mailing
address, phone number, fax number, and e-mail address.
■ Indicate your preferences:
• suggested session where paper may be best suited
• oral presentation or poster
■ If your submission is invited, please indicate that your abstract is invited along with the session title where your talk will be presented

The Organizing Committee will select papers, and notify authors of acceptance and mode of presentation.

Confirmation

Receipt of abstracts sent by e-mail will be confirmed by e-mail. If you do not receive your confirmation within 2 weeks of your submission, please contact:
Denise Flaherty, Conference Coordinator
E-mail: flaherty@icdd.com
Phone: +610.325.9814